Nitrofurantoin and Hepatitis - a phase IV clinical study of FDA data

Summary:

Hepatitis is reported as a side effect among people who take Nitrofurantoin (nitrofurantoin, macrocrystalline), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cymbalta, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Hepatitis when taking Nitrofurantoin. It is created by eHealthMe based on reports of 4,140 people who have side effects when taking Nitrofurantoin from the FDA, and is updated regularly.

What is Nitrofurantoin?

Nitrofurantoin has active ingredients of nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 4,837 Nitrofurantoin users. Check the latest studies of Nitrofurantoin.

What is Hepatitis?

Hepatitis (inflammation of the liver) is found to be associated with 1,470 drugs and 1,522 conditions by eHealthMe. Check the latest studies of Hepatitis.



On Jul, 10, 2026

4,140 people reported to have side effects when taking Nitrofurantoin.
Among them, 48 people (1.16%) have Hepatitis.

Could Nitrofurantoin cause Hepatitis?

Among these 48 people:

How long have people been on Nitrofurantoin when they have Hepatitis? *

  • < 1 month: 60.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 13.33 %
  • 2 - 5 years: 20.0 %
  • 5 - 10 years: 6.67 %
  • 10+ years: 0.0 %

What is the gender of people who have Hepatitis when taking Nitrofurantoin? *

  • female: 95.65 %
  • male: 4.35 %

What is the age of people who have Hepatitis when taking Nitrofurantoin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5.41 %
  • 40-49: 8.11 %
  • 50-59: 18.92 %
  • 60+: 67.57 %

What are other drugs people take besides Nitrofurantoin? *

  1. Furosemide: 5 people, 10.42%
  2. Cymbalta: 5 people, 10.42%
  3. Omeprazole: 4 people, 8.33%
  4. Ibuprofen: 4 people, 8.33%
  5. Aspirin: 4 people, 8.33%
  6. Lexapro: 3 people, 6.25%
  7. Lopid: 3 people, 6.25%
  8. Loratadine: 3 people, 6.25%
  9. Glucophage: 3 people, 6.25%
  10. Meclizine: 3 people, 6.25%

What are other side effects people have besides Hepatitis? *

  1. Pain In Extremity: 6 people, 12.50%
  2. Stress And Anxiety: 5 people, 10.42%
  3. Fatigue (feeling of tiredness): 5 people, 10.42%
  4. Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 5 people, 10.42%
  5. Fever: 5 people, 10.42%
  6. Liver Function Tests Nos Abnormal: 4 people, 8.33%
  7. Back Pain: 4 people, 8.33%
  8. Chest Pain: 4 people, 8.33%
  9. Rashes (redness): 4 people, 8.33%
  10. Liver Injury: 4 people, 8.33%

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 10.42%
  2. Urination - Painful: 2 people, 4.17%
  3. Muscle Spasms (muscle contraction): 2 people, 4.17%
  4. Depression: 2 people, 4.17%
  5. Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 2 people, 4.17%
  6. Facial Neuralgia (pain of face): 2 people, 4.17%
  7. High Blood Pressure: 2 people, 4.17%
  8. Neuralgia (pain in one or more nerves): 2 people, 4.17%
  9. Liver Injury: 1 person, 2.08%
  10. Joint Pain: 1 person, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrofurantoin and have Hepatitis?

- Check whether Hepatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nitrofurantoin:

Hepatitis treatments and more:

How severe was Hepatitis and when was it recovered:

Expand to all the drugs that have ingredients of nitrofurantoin, macrocrystalline:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nitrofurantoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis:

Browse all the conditions that are associated with Hepatitis:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on nitrofurantoin, macrocrystalline (the active ingredients of Nitrofurantoin) and Nitrofurantoin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: